In vitro models for liver toxicity testing
Citations Over Time
Abstract
Over the years, various liver-derived in vitro model systems have been developed to enable investigation of the potential adverse effects of chemicals and drugs. Liver tissue slices, isolated microsomes, perfused liver, immortalized cell lines, and primary hepatocytes have been used extensively. Immortalized cell lines and primary isolated liver cells are currently most widely used in vitro models for liver toxicity testing. Limited throughput, loss of viability, and decreases in liver-specific functionality and gene expression are common shortcomings of these models. Recent developments in the field of in vitro hepatotoxicity include three-dimensional tissue constructs and bioartificial livers, co-cultures of various cell types with hepatocytes, and differentiation of stem cells into hepatic lineage-like cells. In an attempt to provide a more physiological environment for cultured liver cells, some of the novel cell culture systems incorporate fluid flow, micro-circulation, and other forms of organotypic microenvironments. Co-cultures aim to preserve liver-specific morphology and functionality beyond those provided by cultures of pure parenchymal cells. Stem cells, both embryonic- and adult tissue-derived, may provide a limitless supply of hepatocytes from multiple individuals to improve reproducibility and enable testing of the individual-specific toxicity. This review describes various traditional and novel in vitro liver models and provides a perspective on the challenges and opportunities afforded by each individual test system.
Related Papers
- → Advances in cell sources of hepatocytes for bioartificial liver(2012)32 cited
- → Life support of artificial liver: development of a bioartificial liver to treat liver failure(2008)24 cited
- → Spontaneous self-assembly of liver organoids from differentiated human cells(2018)1 cited
- → Hepatocytes and Endothelial Networks in a Fluid-Based In Vitro Model of Liver Drug Metabolism(2020)
- Feature Article : Stem Cell-Based Hepatic Differentiation for Cell Therapy of Liver Diseases(2010)